Seres Therapeutics, Inc. (MCRB) vs MDxHealth S.A. (MDXH)

A side-by-side comparison of Seres Therapeutics, Inc. and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MCRB vs MDXH

growth of $100 · dividends reinvested · last 5y
MCRB -98.0% (-54.1%/yr)MDXH -95.0% (-45.1%/yr)MDXH compounded faster over this window
050100150Start $10020222023202420252026$2$5
MCRB MDXH

MCRB vs MDXH: by the numbers

  • •MDXH is the larger company ($31M vs $28M market cap).
  • •Both run net losses; MDXH's is the smaller (-31.07% vs -1192.94% net margin).
  • •MDXH grew revenue faster over the past five years (42.35% vs -42.51% CAGR).

Metrics side by side

Valuation

MetricMCRBMDXH
P/S ratio14.66N/A
P/B ratio0.80N/A

Profitability

MetricMCRBMDXH
Gross margin-423.83%59.74%
Operating margin-11910.14%-14.28%
Net margin-1192.94%-31.07%
ROE-65.05%N/A
ROIC-103.04%-15.35%

Growth (annualized)

MetricMCRBMDXH
Revenue CAGR (5Y)-42.51%42.35%
Total return CAGR (5Y)-53.37%N/A

Frequently asked

Which has grown faster, MCRB or MDXH?
Over the past five years, MDXH grew revenue faster — MCRB at a -42.51% CAGR versus MDXH at 42.35%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.